Medizinische Universität Graz - Research portal
Selected Publication:
SHR Neuro Cancer Cardio Lipid Metab Microb
Aigner, B; Plötz, SG; Schaller, G.
Triple-negative breast cancer possibly transforming into malignant melanoma due to targeted therapy? A case report and review of literature.
Wien Med Wochenschr. 2013; 163(21-22): 495-498.
Doi: 10.1007/s10354-013-0242-0
(- Case Report)
PubMed
FullText
FullText_MUG
- Leading authors Med Uni Graz
- Sadoghi Birgit
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
- Triple-negative breast cancer (TNBC) is characterized by lacking expression of estrogen receptor and progesterone receptor as well as absence of human epidermal growth factor receptor 2 overexpression and is an aggressive clinical phenotype. We report the case of a 33-year-old woman who has been treated using a targeted approach for TNBC and developed a malignant melanoma metastasis without any primary. Using targeted therapies, tumors can be treated much more effectively, but up to now, we do not know much about potential adverse reactions. Due to the targeted therapy, tumors may be pressurized for transformation. We call for further investigations to rule out the potential risks of targeted therapy in TNBC. This is the first report of a potential transforming of one tumor entity to another by a targeted therapy.
- Find related publications in this database (using NLM MeSH Indexing)
- Adult -
- Antineoplastic Combined Chemotherapy Protocols - adverse effects
- Antineoplastic Combined Chemotherapy Protocols - therapeutic use
- Carcinoma, Ductal, Breast - drug therapy
- Carcinoma, Ductal, Breast - genetics
- Carcinoma, Ductal, Breast - pathology
- Cell Transformation, Neoplastic - drug effects
- Cell Transformation, Neoplastic - genetics
- Cell Transformation, Neoplastic - pathology
- Combined Modality Therapy -
- Cyclooxygenase 2 - genetics
- Disease Progression -
- Fatal Outcome -
- Female -
- Humans -
- Ki-67 Antigen - genetics
- Melanoma - chemically induced
- Melanoma - genetics
- Melanoma - pathology
- Melanoma - secondary
- Molecular Targeted Therapy - adverse effects
- Molecular Targeted Therapy - methods
- Neoplasm Staging -
- Neoplasms, Multiple Primary - drug therapy
- Neoplasms, Multiple Primary - genetics
- Neoplasms, Multiple Primary - pathology
- Neoplasms, Unknown Primary - chemically induced
- Neoplasms, Unknown Primary - genetics
- Neoplasms, Unknown Primary - pathology
- Receptor, Epidermal Growth Factor - genetics
- Receptor, ErbB-2 - genetics
- Spinal Cord Neoplasms - chemically induced
- Spinal Cord Neoplasms - genetics
- Spinal Cord Neoplasms - pathology
- Spinal Cord Neoplasms - secondary
- Triple Negative Breast Neoplasms - drug therapy
- Triple Negative Breast Neoplasms - genetics
- Vascular Endothelial Growth Factor A - genetics